INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2012

Soy isoflavone metabolism by intestinal bacteria, particularly equol production, is hypothesized to influence prostate cancer risk differences across populations.

This article discusses the role of intestinal microbiota and soy isoflavones in prostate cancer prevention. It hypothesizes that dietary intake of soy products and their metabolization into compounds such as equol by intestinal bacteria contribute to prostate cancer incidence differences between Asian and Western populations. The authors suggest that lacking equol-converting bacteria in the intestine may be a risk factor for prostate cancer.

Shows an association, not proof of cause and effect.

Study type
Narrative review / hypothesis
Who was studied
Asian, European/North American, and Japanese emigrant populations (referenced)
What was measured
Prostate cancer risk in relation to soy isoflavones and intestinal bacteria

THE PAPER

Prostate cancer chemoprevention by soy isoflavones: role of intestinal bacteria as the "second human genome".

Akaza H. Cancer Sci, 2012.

PubMed 22372745 ↗DOI 10.1111/j.1349-7006.2012.02257.x ↗

CancerGut & microbiome

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.